P

Inventor

BERG STEFAN

SE39 patents
⚠️ This page may combine multiple inventors who share the name “BERG STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ASTRAZENECA AB

25 patents
US6479497B1Nov 12, 2002

Substituted chroman derivatives

ASTRAZENECA AB16 citations92
US6159971ADec 12, 2000

Combination of a 5-HT reuptake inhibitor and a h5-HT1B anatagonist or partial agonist

ASTRAZENECA AB26 citations92
US6387899B1May 14, 2002

Substituted chroman derivatives

ASTRAZENECA AB18 citations90
US7595319B2Sep 29, 2009

Compounds having selective inhibiting effect at GSK3

ASTRAZENECA AB15 citations83
US7585853B2Sep 8, 2009

Compounds having selective inhibiting effect at GSK3

ASTRAZENECA AB9 citations83
US7342022B2Mar 11, 2008

Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3

ASTRAZENECA AB9 citations82
US7399780B2Jul 15, 2008

3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3

ASTRAZENECA AB12 citations81
US7205314B2Apr 17, 2007

Compounds for the treatment of dementia related diseases

ASTRAZENECA AB12 citations80
US6159970ADec 12, 2000

Combination of a monoamine oxidase inhibitor and a h5-HT1B antagonist or partial agonist

ASTRAZENECA AB7 citations73
US7855213B2Dec 21, 2010

Compounds

ASTRAZENECA AB7 citations71
US6384225B1May 7, 2002

Intermediates in the preparation of substituted chroman derivatives

ASTRAZENECA AB7 citations71
US7595321B2Sep 29, 2009

Compounds having selective inhibiting effect at GSK3

ASTRAZENECA AB4 citations62
US7056939B2Jun 6, 2006

4-(4Methoxybenzyl)-n′-(5-nitro1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3 (gsk3)

ASTRAZENECA AB4 citations62
US6291458B1Sep 18, 2001

Morpholinobenzamide salts

ASTRAZENECA AB3 citations62
US6159972ADec 12, 2000

Combination of a selective 5-HT1A antagonist and a selective ub. h5-HT.s1B antagonist or partial agonist

ASTRAZENECA AB6 citations62
US7078410B2Jul 18, 2006

2-arylamino-pyrimidines for the treatment of GSK3-related disorders

ASTRAZENECA AB7 citations61
US6548498B1Apr 15, 2003

Substituted indan derivatives

ASTRAZENECA AB2 citations61
US6534652B2Mar 18, 2003

Intermediates for the preparation of substituted 1,2,3,4-tetrahydronaphthalene derivatives

ASTRAZENECA AB0 citations52
US6410532B2Jun 25, 2002

Substituted 1,2,3,4-tetrahydronaphthalene derivatives

ASTRAZENECA AB0 citations52
US7683067B2Mar 23, 2010

3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)

ASTRAZENECA AB1 citations51
US7384943B2Jun 10, 2008

Substituted chroman derivatives

ASTRAZENECA AB0 citations51
US7345050B2Mar 18, 2008

Pyrimidine compounds

ASTRAZENECA AB1 citations51
US6670359B2Dec 30, 2003

Substituted chroman derivatives

ASTRAZENECA AB0 citations51
US7439356B2Oct 21, 2008

Substituted indan derivatives

ASTRAZENECA AB0 citations50
US6410530B1Jun 25, 2002

Substituted 1,2,3,4-tetrahydronaphthalene derivatives

ASTRAZENECA AB1 citations50

ELEIKO GROUP AB

4 patents

BASF AG

2 patents

ASTRA AB

2 patents

ELEFONAKTIEBOLAGET L M ERICSSO

1 patent

TELES JOAQUIM HENRIQUE

1 patent

FLEISCHMANN KARL-HEINZ

1 patent

ASTRAZANECA AB

1 patent

TERRILL STEPHEN

1 patent

FORD GLOBAL TECH LLC

1 patent